Preconception GLP RA-1

ADA Member Exclusive Webinar

This interactive session will explore familiar sources of funding for diabetes education programs, highlight the unique strengths of DSMES initiatives that resonate with grant funders, and provide a practical approach to designing successful grant proposals, programs, and partnerships.

Overview

This interactive session will explore familiar sources of funding for diabetes education programs, highlight the unique strengths of DSMES initiatives that resonate with grant funders, and provide a practical approach to designing successful grant proposals, programs, and partnerships. By the end of the webinar, attendees will understand the indicated use of GLP-1 receptor agonists (GLP-1 RAs) and current recommendations in the preconception period, recognize the risks and benefits of preconception use of GLP-1 RAs, and review the evidence regarding GLP-1 RA use during and after pregnancy. The session will conclude with actionable insights and a live Q&A to help you take the following steps in securing support for your diabetes education efforts.

Learning Objectives

Attendees will know indicated use of GLP-1 RAs and current recommendations in the preconception period
Attendees will know the risks and benefits of preconception use of GLP-1RAs
Attendees will know the evidence regarding use of GLP RA-1 during and after pregnancy

Speakers

	Jacqueline Maya, MD Pediatric Endocrinology at Mass General Brigham for Children
	Christopher Nau, MD Director of Diabetes in Pregnancy Program at University Hospitals

Moderator

Laura Dickens
Assistant Professor of Medicine
Co-Director, Diabetes in Pregnancy Program at University of Chicago Medicine

Summary

Availability:

Registration Required

Expires on Dec 31, 2026

Location:

Online Meeting

Date / Time:

Jan 23, 2026 1:00 PM - 2:00 PM ET

Cost:

FREE

Credit Offered:

No Credit Offered

Create Account